The
NEPHRIC study concludes that:
"...the likelihood for high risk patients to develop contrast
media-induced nephropathy appears to be significantly reduced when
[Visipaque™]... is used rather than a low-osmolar non-ionic
contrast medium."
Please click the heading to read the abstract and view the main graphs,
you can also order a reprint of the study when following this link.
